spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  AXCAN PHARMA 

 HSMN NewsFeed - 27 Mar 2012
InterMune Appoints Mr. Jean-Jacques Bienaime and Dr. Frank Verwiel to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Oct 2007
Axcan Licenses Rights to Cx401, an Innovative Biological Product in Development for the Treatment of Perianal Fistulas, a Significant Unmet Medical Need
Biopharmaceuticals Regenerative Medicine
 HSMN NewsFeed - 2 Aug 2007
Axcan Pharma Submits Complete New Drug Application for ULTRASE
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 14 Jun 2007
Axcan Pharma Initiates MAX-002 Phase III Clinical Trial to Evaluate the Efficacy and Safety of a High-Concentration 1 Gram Mesalamine Suppository
Biopharmaceuticals
 HSMN NewsFeed - 7 May 2007
Axcan Announces the U.S. Launch of PYLERA, an Innovative 3-in-1 Capsule Triple Therapy for the Eradication of Helicobacter Pylori
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 29 Sep 2006
Axcan Receives FDA Approval Letter for PYLERA'TM' -Formerly Known as HELIZIDE-, an Innovative 3-in-1 Capsule Triple Therapy for the Eradication of Helicobacter Pylori
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 26 Sep 2006
Axcan and AGI Therapeutics Sign Exclusive License and Co-Development Agreement for the Next-Generation Therapy for GERD and the Control of Nocturnal Acid Breakthrough
Biopharmaceuticals Gastroenterology Licensing
 HSMN NewsFeed - 10 May 2006
Axcan Pharma appoints new Senior Vice President and Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Mar 2006
Axcan submits FDA amendment to its new drug application for HELIZIDE
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 22 Feb 2006
Axcan announces outcome of ITAX International Phase III clinical trial
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 20 Jan 2006
Axcan Appoints Steve Gannon Senior Vice President and Chief Financial Officer
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 34

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 34 additional stories matching:
AXCAN PHARMA
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.